Apixaban and Topiramate: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Aug 8, 2026 · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Topiramate
Apixaban
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Let me walk you through this one. Apixaban (Eliquis) is a blood thinner that helps prevent dangerous blood clots. Topiramate (Topamax) can speed up how fast your body breaks down apixaban, which may leave less of the blood thinner in your system.
If apixaban levels drop too low, it might not protect you as well from clots. I want to be clear though: this concern is theoretical, meaning it is based on how these drugs work rather than lots of real-world cases. The good news is your care team can manage this by keeping a close eye on you and tailoring your treatment. Please don't stop either medication on your own, just talk with your pharmacist or doctor.
Effect: Topiramate may induce CYP3A4-mediated metabolism of apixaban, decreasing apixaban exposure (AUC/Cmax) and risking subtherapeutic anticoagulation and thrombotic events.
- Direction: Reduced apixaban effect (neither drug is affected as a prodrug; apixaban is the active anticoagulant).
- Evidence: Theoretical; magnitude not quantified.
- Onset: Unspecified.
- Management: Use with caution; avoid coadministration if possible, especially alongside other agents that lower apixaban levels. Monitor for thromboembolic signs/symptoms; there is no validated routine apixaban level assay for dose titration, so anticoagulation strategy should be individualized by the care team.
What happens
Decreased apixaban exposure and possible subtherapeutic anticoagulation which could lead to a thrombotic event
Interaction Deep Dive
Because topiramate acts as a CYP3A4 inducer, giving it alongside apixaban can lower apixaban concentrations, particularly when additional agents that also decrease apixaban levels are present, so this combination warrants caution1. Where feasible, the two drugs should not be given together2.
Why it happens (mechanism)
Induction of CYP3A4-mediated apixaban metabolism by topiramate
How to manage this interaction
Here is how a care team typically handles this:
- Keep taking both medications as prescribed unless your prescriber tells you otherwise.
- Because this combination may lower your blood thinner's protection, your team may avoid using them together when a good alternative exists, or watch you more closely if they stay combined.
- Your care team may monitor you more closely for signs of clotting and individualize your treatment plan.
- Watch for warning signs of a clot, such as leg swelling or pain, sudden shortness of breath, chest pain, or trouble speaking, and seek care right away.
- Tell your pharmacist about any other medicines, since some can further lower apixaban levels.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) A retrospective cohort study using propensity score matching in adults (n=14,078 eligible episodes) receiving direct-acting oral anticoagulant (DOAC) therapy (apixaban, dabigatran, or rivaroxaban) together with enzyme-inducing antiseizure medications (EI-ASMs), such as carbamazepine, oxcarbazepine, phenobarbital, phenytoin, primidone, or topiramate, found no difference in the risk of thromboembolic events when compared with non-EI-ASMs (adjusted HR, 1.1 [95% CI, 0.82 to 1.46]). A secondary analysis (n=14,158 eligible episodes) showed a significant decrease in major bleeding events with concurrent use of DOACs and EI-ASMs relative to non-EI-ASMs (adjusted HR, 0.63 [95% CI, 0.44 to 0.89]) 3.
Common questions
Can I take Apixaban and Topiramate together?
Topiramate may lower apixaban levels and weaken its clot protection, so let your pharmacist or doctor know you take both; they can monitor you closely or choose an alternative if needed. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Apixaban and Topiramate interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Apixaban and Topiramate interaction managed?
Here is how a care team typically handles this: Keep taking both medications as prescribed unless your prescriber tells you otherwise. Because this combination may lower your blood thinner's protection, your team may avoid using them together when a good alternative exists, or watch you more closely if they stay combined. Your care team may monitor you more closely for signs of clotting and indivi… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Apixaban or Topiramate need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (3)
- Steffel J, Collins R, Antz M, et al: 2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Europace 2021; 23(10):1612-1676.
- Stollberger C & Finsterer J: Interactions between non-vitamin K oral anticoagulants and antiepileptic drugs. Epilepsy Res 2016; 126:98-101. PubMed
- Acton EK, Hennessy S, Gelfand MA, et al: Direct-acting oral anticoagulants and antiseizure medications for atrial fibrillation and epilepsy and risk of thromboembolic events. JAMA Neurol 2024; Epub:Epub. DOI
Keep reading about Topiramate
Keep reading about Apixaban
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist